It's more a question of why did it go up in the first place. In Jan 2020 Uscom China had a backlog of USCOM1A sales go through due to reapproval just as Covid19 hit China. At the same time the market was looking for a covid19 stock and the 1A getting fast tracked for SARS many years ago made it a good target for hysteria. Even with Chinese recommendation (indirectly) of the 1A for covid19 treatment the market quickly worked out it wouldn't result in much action so it fell back down. Further approval delays and Europe/US being harder markets due to pressure on their hospital systems also didn't help.
To a lesser degree currency fluctuations also impacted. We'd prefer a weaker AUD and that will impact next weeks 4c as well.
Ann: Uscom China Listed as National High Technology Enterprise, page-26
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable